🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

144,67 USD

Máx. histórico

156,45

70 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-7,53%

Rango 52 semanas

82,01 – 156,92

Variación hoy

-2,49%

Cierre anterior

148,36

Rango de hoy

143,47 – 147,62

Volumen hoy

8.862.415

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,42%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
146,13 (puede no estar actualizado)
Dividend yield
2,29% (puede no estar actualizado)
Precio objetivo analistas
160,29 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 12 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,35%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/05/2023 115,88 116,76 115,29 116,08 -0,25% 1,27% 4.278.200
15/05/2023 117,14 117,74 115,49 116,37 -0,66% 1,92% 5.697.200
12/05/2023 118,00 118,55 116,70 117,14 -0,35% 1,57% 5.233.100
11/05/2023 117,58 117,79 116,38 117,55 -0,30% 1,20% 5.596.700
10/05/2023 117,41 118,17 116,42 117,90 +0,40% 1,49% 5.605.400
09/05/2023 118,25 118,63 117,34 117,43 -0,80% 1,09% 4.933.100
08/05/2023 117,08 118,44 116,44 118,38 +0,59% 1,71% 5.157.300
05/05/2023 117,38 117,89 116,56 117,68 +0,26% 1,13% 4.534.000
04/05/2023 118,00 118,00 116,49 117,37 -0,72% 1,28% 6.490.200
03/05/2023 118,35 119,65 117,93 118,22 +0,28% 1,45% 6.738.600
02/05/2023 116,67 118,39 115,81 117,89 +1,33% 2,21% 8.175.600
01/05/2023 115,80 116,60 115,27 116,34 +0,75% 1,15% 5.238.900
28/04/2023 114,36 115,53 113,46 115,47 +0,27% 1,81% 8.050.400
27/04/2023 114,60 115,36 110,66 115,16 +1,53% 4,10% 9.975.200
26/04/2023 115,20 115,20 112,72 113,43 -2,66% 2,15% 6.607.900
25/04/2023 116,22 116,86 115,91 116,53 +0,51% 0,82% 5.662.800
24/04/2023 115,64 116,28 114,77 115,94 +0,49% 1,31% 4.299.100
21/04/2023 114,87 115,65 114,59 115,37 +1,05% 0,92% 6.554.600
20/04/2023 114,18 114,52 113,00 114,17 +0,04% 1,33% 4.657.900
19/04/2023 114,49 115,39 114,01 114,13 -0,61% 1,21% 4.683.400
18/04/2023 114,48 115,12 113,73 114,83 -0,16% 1,21% 5.454.500
17/04/2023 115,69 116,45 114,20 115,01 -0,26% 1,94% 6.575.500
14/04/2023 115,74 116,17 114,66 115,31 -0,23% 1,30% 5.005.100
13/04/2023 114,97 115,82 113,65 115,58 +1,61% 1,89% 7.332.300
12/04/2023 112,25 114,31 111,88 113,75 +1,12% 2,16% 6.136.700
11/04/2023 112,72 113,31 112,32 112,49 -0,11% 0,88% 5.639.800
10/04/2023 112,96 113,09 111,17 112,61 +0,25% 1,70% 6.446.500
06/04/2023 113,00 114,17 111,64 112,33 +0,38% 2,24% 6.894.500
05/04/2023 109,91 112,34 109,58 111,91 +2,83% 2,51% 8.006.100
04/04/2023 108,70 109,34 108,16 108,83 -0,04% 1,09% 6.108.200